News
Rese-cel is the lead clinical candidate in development by Cabaletta Bio, a biotechnology company focused on developing and launching the first curative targeted cell therapies designed ...
--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has concluded the Technology Adoption Program (TAP) on its automated cell therapy manufacturing ...
Artist Lari Pittman talks about his relationship to his hometown, Los Angeles, as well as the ways in which time and balance are investigated through his paintings. ART21: Do you often think about who ...
You’re not alone: Everyone has to start their vinyl collection somewhere. That means getting some of your favorite music in analog format. While we always recommend you hit up a local ...
VIENNA, Va. - CEL-SCI Corporation (NYSE American: CVM), whose shares have declined nearly 85% over the past year according to InvestingPro data, today shared an update on its ongoing efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results